The balance of macrophage subsets may be customised at mucosal surfaces
- PMID: 1466903
- DOI: 10.1111/j.1574-6968.1992.tb05915.x
The balance of macrophage subsets may be customised at mucosal surfaces
Abstract
Monoclonal antibodies (mAbs) can discriminate phagocytes (mAb, RFD7+), antigen presenting cells (mAb, RFD1+) and suppressor macrophages (mAbs, RFD1+RFD7+). Here we compare proportions of these subsets in normal mucosa and investigate changes associated with inflammatory disease. Biopsies were obtained from normal and inflamed lung, gut and skin. Cryostat sections were then analysed using mAbs RFD1 and RFD7. At normal mucosal surfaces the RFD1+RFD7+ suppressor cells consistently formed a major population: lung, RFD1+ 11.4%, RFD7+ 43.3%, RFD1+RFD7+ 45.2% and in gut, RFD1+ 37%, RFD7+ 12%, RFD1+RFD7+ 51% while in the skin the three subsets were in relatively equal proportions (RFD1+ 30%, RFD7+ 37%, RFD1+RFD7+ 33%). In inflamed eczematous skin the percentage of RFD1+RFD7+ increased at the expense of RFD1+ and RFD7+ cells whereas in inflamed mucosa the RFD1+RFD7+ population was significantly reduced (asthmatic lung 29%, RFD1+RFD7+, colitis 31% RFD1+RFD7+). In the lung this reduction was concomitant with a rise in RFD1+ cells while in the gut the RFD7+ population increased. It is concluded that balance of macrophage subsets may be customised at mucosal surfaces to sustain suppression of T cell reactivity. Inflammation here is associated with a loss of this suppression.
Similar articles
-
Phenotypic analysis of IL-10-treated macrophages using the monoclonal antibodies RFD1 and RFD7.Pathobiology. 1999;67(5-6):249-52. doi: 10.1159/000028103. Pathobiology. 1999. PMID: 10725795
-
Mucosal macrophage subsets of the gut in HIV: decrease in antigen-presenting cell phenotype.Clin Exp Immunol. 1993 Jun;92(3):442-7. doi: 10.1111/j.1365-2249.1993.tb03418.x. Clin Exp Immunol. 1993. PMID: 8513576 Free PMC article.
-
Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies.Scand J Immunol. 1986 Sep;24(3):351-7. doi: 10.1111/j.1365-3083.1986.tb02104.x. Scand J Immunol. 1986. PMID: 3529367
-
Intestinal macrophages: well educated exceptions from the rule.Trends Immunol. 2013 Apr;34(4):162-8. doi: 10.1016/j.it.2013.02.001. Epub 2013 Mar 13. Trends Immunol. 2013. PMID: 23477922 Review.
-
Intestinal macrophages - specialised adaptation to a unique environment.Eur J Immunol. 2011 Sep;41(9):2494-8. doi: 10.1002/eji.201141714. Eur J Immunol. 2011. PMID: 21952804 Review.
Cited by
-
Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.Ann R Coll Surg Engl. 2002 Sep;84(5):314-8. doi: 10.1308/003588402760452402. Ann R Coll Surg Engl. 2002. PMID: 12398121 Free PMC article. Review.
-
Asbestos and silica-induced changes in human alveolar macrophage phenotype.Environ Health Perspect. 1997 Sep;105 Suppl 5(Suppl 5):1139-42. doi: 10.1289/ehp.97105s51139. Environ Health Perspect. 1997. PMID: 9400713 Free PMC article.
-
Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.Springer Semin Immunopathol. 2004 Feb;25(3-4):237-55. doi: 10.1007/s00281-003-0148-9. Epub 2003 Oct 8. Springer Semin Immunopathol. 2004. PMID: 15007629 Review.
-
Distribution of immunocompetent cells in the bronchial wall of clinically healthy subjects showing bronchial hyperresponsiveness.Thorax. 1993 Nov;48(11):1125-9. doi: 10.1136/thx.48.11.1125. Thorax. 1993. PMID: 8296256 Free PMC article.
-
Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time.Thorax. 1998 Sep;53(9):753-61. doi: 10.1136/thx.53.9.753. Thorax. 1998. PMID: 10319057 Free PMC article. Clinical Trial.